Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pupillary Unrest as Opioid Indicator in 40-60s
NCT05391555Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Oct 2022
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by University of California, San Francisco. Primary endpoint: Area Under the Time Concentration Curve (AUROC) at 35 minutes. Started Oct 2022; status: completed.
Beyond the preview
Go deeper on NCT05391555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05391555.